The new tubulin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma

International Journal of Radiation Oncology Biology Physics

Volumn 46, Issue 3, 2000, Pages 645-652

  Eikesdal, Hans Petter ^a   Schem, Baard Christian ^a   Mella, Olav ^a   Dahl, Olav ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

BT4An; Combretastatin A 4 disodium phosphate; Hyperthermia; Laser Doppler flowmetry

Indexed keywords

ANGIOGENESIS INHIBITOR; COMBRETASTATIN A4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CYTOTOXICITY; FEMALE; GLIOMA; HYPERTHERMIC THERAPY; LASER FLOWMETER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR BLOOD FLOW;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; COMBINED MODALITY THERAPY; DIARRHEA; FEMALE; GLIOMA; HYPERTHERMIA, INDUCED; LASER-DOPPLER FLOWMETRY; MALE; RADIOBIOLOGY; RATS; RATS, INBRED STRAINS; STILBENES; TIME FACTORS;

EID: 0033955698     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00451-4     Document Type: Article

References (44)

1. Denekamp J., Hill S.A., Hobson B. Vascular occlusion and tumour cell death. Eur J Cancer Clin Oncol. 19:1983;271-275.
2. Denekamp J. Vascular attack as a therapeutic strategy for cancer. Cancer Metastasis Rev. 9:1990;267-282.
3. Brown J.M., Giaccia A.J. The unique physiology of solid tumors Opportunities (and problems) for cancer therapy . Cancer Res. 58:1998;1408-1416.
4. Boehm T., Folkman J., Browder T., O'Reilly M.S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature. 390:1997;404-407.
5. Kerbel R.S. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anticancer therapeutic agents. BioEssays. 13:1991;31-36.
6. Baguley B.C., Holdaway K.M., Thomsen L.L., Zhuang L., Zwi L.J. Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine Evidence for a vascular mechanism . Eur J Cancer. 27:1991;482-487.
7. Hill S.A., Lonergan S.J., Denekamp J., Chaplin D.J. Vinca alkaloids Anti-vascular effects in a murine tumour . Eur J Cancer. 29A:1993;1320-1324.
8. Chaplin D., Pettit G., Parkins C., Hill S. Antivascular approaches to solid tumour therapy Evaluation of tubulin binding agents . Br J Cancer. 74:1996;S86-S88.
9. Pettit G.R., Singh S.B., Hamel E., Lin C.M., Alberts D.S., Garcia-Kendall D. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4. Experientia. 45:1989;209-211.
10. Pettit G.R., Temple C., Narayanan V.L., Varma R., Simpson M.J., Boyd M.R., Rener G.A., Bansal N. Antineoplastic agents 322 Synthesis of combretastatin A-4 prodrugs . Anticancer Drug Des. 10:1995;299-309.
11. Dark G.G., Hill S.A., Prise V.E., Tozer G.M., Pettit G.R., Chaplin D.J. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. Cancer Res. 57:1997;1829-1834.
12. Tozer G.M., Prise V.E., Wilson J., Locke R.J., Vojnovic B., Stratford M.R., Dennis M.F., Chaplin D.J. Combretastatin A-4 phosphate as a tumor vascular-targeting agent Early effects in tumors and normal tissues . Cancer Res. 59:1999;1626-1634.
13. Horsman M.R., Ehrnrooth E., Ladekarl M., Overgaard J. The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors. Int J Radiat Oncol Biol Phys. 42:1998;895-898.
14. Song C.W. Effect of local hyperthermia on blood flow and microenvironment A review . Cancer Res Suppl. 44:1984;4721s-4730s.
15. Rofstad E.K., Solesvik O.V., Brustad T. Tumour growth delay, cell inactivation and vascular damage following hyperthermic treatment of a human melanoma xenograft. Int J Cancer Clin Oncol. 20:1984;1295-1303.
16. Waterman F.M., Tupchong L., Nerlinger R.E., Matthews J. Blood flow in human tumors during local hyperthermia. Int J Radiat Oncol Biol Phys. 20:1990;1255-1262.
17. Fajardo L.F., Prionas S.D., Kowalski J., Kwan H.H. Hyperthermia inhibits angiogenesis. Radiat Res. 114:1988;297-306.
18. Vaupel P.W., Kelleher D.K. Metabolic status and reaction to heat of normal and tumor tissue. Seegenschmiedt M.H., Fessenden P., Vernon C.C. Thermoradiotherapy and thermochemotherapy. Vol. 1:1995;157-176 Springer-Verlag, Berlin, Heidelberg, New York.
19. Olch A.J., Kaiser L.R., Silberman A.W., Storm F.K., Graham L.S., Morton D.L. Blood flow in human tumors during hyperthermia therapy Demonstration of vasoregulation and an applicable physiological model . J Surg Oncol. 23:1983;125-132.
20. Prescott D.M., Samulski T.V., Dewhirst M.W., Page R.L., Thrall D.E., Dodge R.K., Oleson J.R. Use of nitroprusside to increase tissue temperature during local hyperthermia in normal and tumor-bearing dogs. Int J Radiat Oncol Biol Phys. 23:1992;377-385.
21. Krossnes B.K., Mella O., Dahl O. Use of the vasodilator sodium nitroprusside during local hyperthermia Effects on tumor temperature and tumor response in a rat tumor model . Int J Radiat Oncol Biol Phys. 36:1996;403-415.
22. Prescott D.M. Manipulation of physiological parameters during hyperthermia. Seegenschmiedt M.H., Fessenden P., Vernon C.C. Thermoradiotherapy and thermochemotherapy. Vol. 1:1995;177-189 Springer-Verlag, Berlin, Heidelberg, New York.
23. Lyng H., Rofstad E. Thermal dose and secondary tumour cell death. Int J Hyperthermia. 9:1993;755-761.
24. Beauregard D., Thelwall P., Chaplin D., Hill S., Adams G., Brindle K. Magnetic resonance imaging and spectroscopy of combretastatin A-4 prodrug-induced disruption of tumour perfusion and energetic status. Br J Cancer. 77:1998;1761-1767.
25. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors A review . Cancer Res. 49:1989;6449-6465.
26. Dewey W. The search for critical cellular targets damaged by heat. Radiat Res. 120:1989;191-204.
27. 4A) in vivo. Cancer. 52:1983;983-987.
28. Scopman E.M., van Bree C., Bakker P.J.M., Kipp J.B.A., Barendsen G.W. Hyperthermia-enhanced effectiveness of mitoxantrone in an experimental rat tumour. Int J Hyperthermia. 12:1996;241-254.
29. Monge O.R., Rofstad E.K., Kaalhus O. Thermochemotherapy in vivo of a C3H mouse mammary carcinoma Single fraction heat and drug treatment . Eur J Cancer Clin Oncol. 24:1988;1661-1669.
30. Dumontet C., Bodin F., Michal Y. Potential interactions between antitubulin agents and temperature Implications for modulation of multidrug resistance . Clin Cancer Res. 4:1998;1563-1566.
31. Mella O., Bjerkvig R., Schem B., Dahl O., Laerum O. A cerebral glioma model for experimental therapy and in vivo invasion studies in syngenic BD IX rats. J Neuro-Oncol. 9:1990;93-104.
32. Flecknell P., Mitchell M. Midazolam and fentanyl-fluanisone Assessment of anesthetic effect in laboratory rodents and rabbits . Lab Anim. 18:1984;143-146.
33. Stern M.D. In vivo evaluation of microcirculation by coherent light scattering. Nature. 254:1975;56-58.
34. Smits G.J., Roman R.J., Lombard J.H. Evaluation of laser-Doppler flowmetry as a measure of tissue blood flow. J Appl Physiol. 61:1986;666-672.
35. Mosmann T. Rapid colorimetric assay for cellular growth and survival Application to proliferation and cytotoxicity assays . J Immunol Meth. 65:1983;55-63.
36. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay Assessment of chemosensitivity testing . Cancer Res. 47:1987;936-942.
37. Mitruka B.M., Rawnsley H.M. Clinical biochemical and hematological reference values in normal experimental animals. 1977;Masson Publishing USA, New York, Paris, Barcelona, Milan.
38. Ohsumi K., Nakagawa R., Fukuda Y., Hatanaka T., Morinaga Y., Nihei Y., Ohishi K., Suga Y., Akiyama Y., Tsuji T. Novel combretastatin analogues effective against murine solid tumors Design and structure-activity relationships . J Med Chem. 41:1998;3022-3032.
39. Iyer S., Chaplin D.J., Rosenthal D.S., Boulares A.H., Li L.Y., Smulson M.E. Induction of apoptosis in proliferating human endothelial cells by the tumor-specific antiangiogenesis agent combretastatin A-4. Cancer Res. 58:1998;4510-4514.
40. Reinhold H.S., Endrich B. Tumour microcirculation as a target for hyperthermia. Int J Hyperthermia. 2:1986;111-137.
41. 4A tumours. Int J Hyperthermia. 1:1985;171-183.
42. Streffer C. Molecular and cellular mechanisms of hyperthermia. Seegenschmiedt M.H., Fessenden P., Vernon C.C. Thermoradiotherapy and thermochemotherapy. Vol. 1:1995;47-74 Springer-Verlag, Berlin, Heidelberg, New York.
43. 4An rat tumour model . Int J Hyperthermia. 14:1998;403-416.
44. Coss R.A., Linnemans W.A.M. The effect of hyperthermia on the cytoskeleton A review . Int J Hyperthermia. 12:1996;173-196.